Citigroup Inc Novartis Ag Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Novartis Ag stock. As of the latest transaction made, Citigroup Inc holds 216,336 shares of NVS stock, worth $23.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
216,336
Previous 294,178
26.46%
Holding current value
$23.5 Million
Previous $33.8 Million
37.79%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$889 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$746 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$606 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $234B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...